IMS MAXIMS Comments on the Public Accounts Committee Hearing and NAO Report into NPfIT

IMS MAXIMSFollowing the recent UK Parliament Public Accounts Committee hearing and NAO (National Audit Office) Report, commenting Shane Tickell, CEO of UK clinical IT company IMS MAXIMS, said:

"Today's PAC committee hearing and last week's NAO report provide a damning picture of the National Programme from initial concept through to execution. By now the UK should have had among the best nationwide electronic patient record systems in the world. All that was needed was to set national standards and demand high levels of interoperability, then let trusts choose their own solution. This would have given smaller, more innovative suppliers the chance to provide hospitals with systems that worked and which met their real needs.

"Instead we seem to be in a position where - like the banks - the NPfIT contracts are seen as too big to be allowed to fail, and everyone else has to pay the price. This has left the Government trying to salvage a project which should have been abandoned, or completely re-engineered, long ago. The NHS and its patients have been severely let down.

"If the Government really wants an Information Revolution it should revitalise the drive for a nationwide electronic patient record systems and ease the terms and conditions so that bespoke suppliers in healthcare can compete, which ensures that clinicians have access to all relevant patient data in real time. There have been warm words about encouraging greater choice and creating more opportunities to new suppliers, but swift and decisive action is needed. If savings can be made from the remaining NPfIT contracts the money should be reinvested into helping trusts find the IT solutions they need. This relatively small-scale financial stimulus would do much to help patients, hospitals and the healthcare IT sector."

About IMS MAXIMS
IMS MAXIMS specialises in developing clinical and administrative software solutions and currently supports more than 100 organisations and 20,000 users of IMS MAXIMS products.

To find out more about IMS MAXIMS and its products visit www.imsmaxims.com.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...